Better response with conjugate vaccine than with polysaccaride vaccine 12 months after rituximab treatment in lymphoma patients

British Journal of Haematology

Volumn 156, Issue 3, 2012, Pages 407-409

  Svensson, Magnus ^a   Dahlin, Ulrika ^b   Kimby, Eva ^b  

^a Mälarsjukhuset Eskilstuna ^*  (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Immune therapy; Immunization; Lymphoma; Rituximab; Vaccine

Indexed keywords

ACT HIB; CD19 ANTIGEN; CD20 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN G ANTIBODY; PNEUMO23; PNEUMOCOCCUS VACCINE; PREDNISOLONE; RITUXIMAB; UNCLASSIFIED DRUG; VINCRISTINE;

ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; B LYMPHOCYTE; CANCER STAGING; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FOLLICULAR LYMPHOMA; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; HUMORAL IMMUNITY; INFECTION RISK; LETTER; LYMPHOCYTE COUNT; MALE; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; OPEN STUDY; OUTCOME ASSESSMENT; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVACCINATION; TREATMENT RESPONSE;

AGED; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIBODY FORMATION; ANTINEOPLASTIC AGENTS; BACTERIAL CAPSULES; COMBINED MODALITY THERAPY; FEMALE; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS VACCINES; HUMANS; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; PNEUMOCOCCAL VACCINES; POLYSACCHARIDES, BACTERIAL; STREPTOCOCCUS PNEUMONIAE; TIME FACTORS; VACCINATION; VACCINES, CONJUGATE;

EID: 84855811745     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08867.x     Document Type: Letter

References (10)

1. Bedognetti, D., Zoppoli, G., Massucco, C., Zanardi, E., Zupo, S., Bruzzone, A., Sertoli, M.R., Balleari, E., Racchi, O., Messina, M., Caltabiano, G., Icardi, G., Durando, P., Marincola, F., Boccardo, F., Ferrarini, M., Ansaldi, F. & De Maria, A. (2011) Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens. Journal of Immunology, 186, 6044-6055.
2. Chaiwatanatorn, K., Lee, N., Grigg, A., Filshie, R. & Firkin, F. (2003) Delayed-onset neutropenia associated with rituximab therapy. British Journal of Haematology, 121, 913-918.
3. Cherif, H., Landgren, O., Konradsen, H.B., Kalin, M. & Bjorkholm, M. (2006) Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases. Vaccine, 24, 75-81.
4. Horwitz, S.M., Negrin, R.S., Blume, K.G., Breslin, S., Stuart, M.J., Stockerl-Goldstein, K.E., Johnston, L.J., Wong, R.M., Shizuru, J.A. & Horning, S.J. (2004) Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma. Blood, 103, 777-783.
5. Konradsen, H.B., Sorensen, U.B. & Henrichsen, J. (1993) A modified enzyme-linked immunosorbent assay for measuring type-specific anti-pneumococcal capsular polysaccharide antibodies. Journal of Immunological Methods, 164, 13-20.
6. Ljungman, P., Nahi, H. & Linde, A. (2005) Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine: a randomised study. British Journal of Haematology, 130, 96-98.
7. McLaughlin, P., Grillo-López, A.J., Link, B.K., Levy, R., Czuczman, M.S., Williams, M.E., Heyman, M.R., Bence-Bruckler, I., White, C.A., Cabanillas, F., Jain, V., Ho, A.D., Lister, J., Wey, K., Shen, D. & Dallaire, B.K. (1998) Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. Journal of Clinical Oncology, 16, 2825-2833.
8. Phipps, D.C., West, J., Eby, R., Koster, M., Madore, D.V. & Quataert, S.A. (1990) An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay. Journal of Immunological Methods, 135, 121-128.
9. Slifka, M.K. & Ahmed, R. (1998) Long-lived plasma cells: a mechanism for maintaining persistent antibody production. Current Opinion in Immunology, 10, 252-258.
10. Tsutsumi, Y., Kanamori, H., Mori, A., Tanaka, J., Asaka, M., Imamura, M. & Masauzi, N. (2005) Reactivation of hepatitis B virus with rituximab. Expert Opinion on Drug Safety, 3, 599-608.